Neuralink Corp. is an American neurotechnology company founded by Elon Musk that is developing implantable brain-computer interfaces (BCIs). Their goal is to create a generalized brain interface to restore autonomy to those with unmet medical needs and unlock human potential. The company has developed a fully implantable and cosmetically invisible brain-computer interface called the N1 Implant, which allows users to control a computer or mobile device wirelessly. The implant consists of biocompatible enclosure, battery, chips and electronics, threads for recording neural activity, and a surgical robot for precise insertion. Neuralink is also building an app that enables users to manipulate a keyboard and mouse using only their mind. The company is actively recruiting individuals with diverse engineering, scientific, and operations expertise.

Neuralink Corp.

Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world.

Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and use on their own. Our device, called the Link, will be able to record from 1024 electrodes and is designed to meet these criteria.

Mirza Canada

Raison

Elon Musk

Craft Ventures

Vy Capital

Gigafund

Valor Equity Partners

Vantage Legacy Capital

Founders Fund

Google Ventures

Blake Byers

Fred Ehrsam

Ken Howery

Robert Nelsen

Sam Altman

Roman Smolevskiy

Neuralink

We’re excited to announce that recruitment is open for our first-in-human clinical trial!

If you're interested in learning more about our clinical trial, check out our recent blog post below or download the study brochure.  

https://lnkd.in/g3bqpCBG 

https://lnkd.in/gw43kV8v

If you’re interested in helping bring this technology to the people who could benefit the most, consider joining us. Explore our open roles: www.neuralink.com/careers.

We’re happy to announce our $280M Series D round.  We’re extremely excited about this next chapter at Neuralink. 

If you’d like to help make the first human experience incredible and work on engineering challenges to restore vision and mobility, come join! https://lnkd.in/gMNC2st

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!

This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.

Recruitment is not yet open for our clinical trial. However, recruitment is open to exceptional people looking to further our mission: to create a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow.

Come join us during this exciting time for our company!

We are committed to excellence in animal care, and take pride in our unwavering dedication to treating each and every animal with empathy, skill, and the utmost respect. The expertise and compassion demonstrated by Neuralink's animal care team is truly remarkable, setting a benchmark for the industry to follow. 
 #respect #empathy #team 

msh id	COM:NEURALINK
symbol	-
name	Neuralink Corp.
homepage url	https://neuralink.com/
country	US
sector	Healthcare
industry	Neurotechnology
market	PRIVATE
employee count	443
crunchbase url	https://www.crunchbase.com/organization/neuralink
linkedin url	https://www.linkedin.com/company/neuralink
founders	-

market cap	5.82B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	85.37
growth score 28	84.24
growth score 90	44.12
growth score 365	82.91

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:NEURALINK

Neuralink Corp.

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-